Get my own profile
Public access
View all7 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Patrick J. HaydenBioSurfaces, Inc.Verified email at biosurfaces.us
- Horst SpielmannFreie Universität BerlinVerified email at fu-berlin.de
- Sandra VerstraelenVerified email at vito.be
- Rodger CurrenCEO, Institute for In Vitro SciencesVerified email at iivs.org
- Sebastian Hoffmannseh consulting + servicesVerified email at seh-cs.com
- Jan MarkusMatTek In Vitro Life Science LaboratoriesVerified email at mattek.com
- Robert LandsiedelBASF SE & FU BerlinVerified email at basf.com
- Andrew WorthEuropean CommissionVerified email at ec.europa.eu
- Thomas HartungChair for Evidence-based Toxicology, Johns Hopkins UniversityVerified email at jhsph.edu
- Erin SpillerUniversity Heidelberg, ZMBHVerified email at zmbh.uni-heidelberg.de
- Monika Schaefer-KortingProfessor of Pharmacology and Toxicology, Freie Universität BerlinVerified email at fu-berlin.de
- Ashraf Mohamed Mohamed MahmoudAssiut UniverstyVerified email at pharm.aun.edu.eg
- João BarrosoProfessor Instituto de Educação da Universidade de LisboaVerified email at ie.ul.pt
- Rafael GozalbesVerified email at protoqsar.com
- Jose Vte. CastellUniversity Hospital La Fe, University of ValenciaVerified email at uv.es
- Theo M. de KokMaastricht UniversityVerified email at maastrichtuniversity.nl
- Djork-Arné ClevertPfizer, VP, Machine Learning ResearchVerified email at pfizer.com
- Cyrille KrulTNO Businessline manager, en Lector Hogeschool UtrechtVerified email at tno.nl
- Rosalinde MasereeuwProfessor of Experimental PharmacologyVerified email at uu.nl
- Stephan SchallerFounder & CEO, esqLABS GmbHVerified email at esqlabs.com